Our name and logo changed on February 1.
Please note that some materials on the site may not yet reflect this change.
Top-ranking researchers, physicians and stakeholder representatives belong to the Medical/Scientific Advisory Committee (M/SAC). The Committee makes recommendations on how Cystic Fibrosis Canada funds should be directed. Members volunteer hundreds of hours each year to ensure fund allocation is balanced, cost-efficient and highly effective.
Knowledgeable members of the Cystic Fibrosis Canada community can serve as Advisory Committee stakeholders. These volunteers play a vital role in M/SAC policy decisions and recommendations. They take part in the review process which allocates funds to outstanding cystic fibrosis research projects, lung transplantation and clinical care. Learn more about the stakeholder membership role, requirements, responsibilities and selection process.
Reviewed/updated: 2011-02-02
